Free Consultation

Fill out the form below or call us at (800) 345-4125.

Thank you! We'll get back to you as soon as possible
Oops! Something went wrong while submitting the form.
Of Counsel · Health Law Alliance

Madeline Tatro

Former In-House Compliance Counsel · Healthcare | Clinical Research Intern · Mayo Clinic | SLU Law, Cum Laude

Madeline Tatro specializes in regulatory compliance and healthcare transactions, with deep experience advising healthcare companies on corporate compliance and fraud risks.

Latest Articles
PBM Audit

HLA’s Latest PBM Win Highlights the Dangers of Inventory Discrepancies

Inventory discrepancies are one of the first things PBMs look for during an audit. Even minor clerical errors like entering the incorrect NDC or failing to return a medication to stock can snowball, creating major financial risks that could place your pharmacy in jeopardy.

April 10, 2026
PBM Audit

Clashing with Caremark: $45,000+ in Clawbacks Fully Reversed for Florida Pharmacy

Health Law Alliance helped n independent pharmacy in Florida reverse over $45,000 in clawbacks.

April 10, 2026
KAP Felony

DOJ Targets Ketamine Clinics: Federal Charges Lead to Prison and Probation for Two Providers

The explosion in demand for ketamine-assisted psychotherapy (“KAP”) has garnered significant media attention over the past few years—and the federal government has taken notice.

April 13, 2026
PBM Audit

Defeating Optum: How HLA Won Full Termination Reversals for 7 New York Pharmacies

Health Law Alliance successfully reversed pending terminations for 7 New York pharmacies. Read more about how our PBM audit team achieved this stunning reversal.

April 6, 2026
Ketamine Marketing

Ketamine Marketing Risks for Mental Health Providers

Ketamine marketing is under increasing regulatory scrutiny, with providers facing risk over claims, off-label promotion, and patient targeting. Even well-intentioned messaging can trigger audits or enforcement if it crosses compliance lines.

March 26, 2026
PBM Audit

Why PBMs are Investigating Provider-Patient Relationships—And What it Means for Your Pharmacy

PBMs are ramping up audit pressure in 2026, now targeting provider-patient relationships to justify recoupments and even network terminations. Without precise documentation, even well-established prescriptions can put pharmacies at serious financial and operational risk.

March 18, 2026
PBM Audit

From Prior Authorization to Network Termination: The PBM Audit Trend Independent Pharmacies Must Watch

PBMs are increasingly targeting pharmacies over their role in the prior authorization process, using vague allegations to justify massive recoupments and even terminations. Without airtight documentation and clear procedures, even compliant pharmacies can face serious financial and legal risk.

March 18, 2026
Ketamine Compliance

Building a Regulatory Compliance Checklist for Ketamine Therapy Providers

Ketamine providers face growing regulatory scrutiny across prescribing, marketing, and care models. A focused compliance checklist is essential to reduce risk and stay ahead of enforcement.

March 18, 2026
Wound Care Audit

What to Expect in a Wound Care Audit - And Why You Shouldn’t Go It Alone

In 2025, wound care audits have become a top enforcement priority for federal and private payors, leaving providers unprepared and facing thousands in recoupments. Understanding how wound care audits progress is crucial to defending your practice from unjust penalties, and engaging counsel early is essential to protecting your practice. Learn how Health Law Alliance can help prepare a strategy-driven defense designed to minimize risk and preserve your practice’s reputation.

November 20, 2025
Wound Care

DOJ Targets Florida Dermatology Practices’ Wound Care Coding

Earlier this year, the DOJ announced a settlement with Florida dermatology practices over allegations of false wound care claims submitted to Medicare. Learn more about the settlement and how Health Law Alliance can protect your wound care practice before regulators come knocking.

November 17, 2025
Telehealth Policy

Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week

Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.

September 30, 2025
OIG

OIG Doubles Down on Increased Oversight for RPM in New Report

On August 28, 2025, the US Department of Health and Human Services’ Office of the Inspector General published a report outlining billing data trends for remote patient monitoring (RPM) in Medicare, renewing its calls for increased oversight into RPM services. Learn more about the reports key findings.

September 30, 2025
Audit Defense

Standing Up for Pharmacies: How HLA Fought and Reversed Optum’s Termination of a New York Pharmacy

In a recent victory, our attorneys at Health Law Alliance achieved a full reversal of Optum’s termination of a New York pharmacy. Read about how HLA fought tirelessly to rebut Optum’s allegations and how Health Law Alliance can defend your pharmacy from an unjust termination.

September 22, 2025
Remote Patient Monitoring

RPM Roundup: Compliance Insights from Recent Remote Patient Monitoring Settlements

Federal enforcement actions are increasingly focused on remote patient monitoring (RPM) services. In this article, we break down two recent settlements involving RPM companies—Health Wealth Safe and Capital Health—and discuss key compliance takeaways for telehealth providers.

August 25, 2025
EKRA compliance

9th Circuit’s Landmark EKRA Ruling—What Providers Should Know

On July 11, 2025, the 9th Circuit upheld a laboratory operator’s convictions for violating EKRA by paying marketing agents to mislead providers into providing patient referrals for medically unnecessary blood tests. In this article, we analyze the 9th Circuit’s ruling and what it means for the future of EKRA enforcement.

August 14, 2025
HIPPA

Proposed HIPAA Security Rule Overhaul: What’s Changing - and Why Telehealth Providers Should Act Now

The proposed changes to the HIPAA Security Rule stand to have a significant impact on telehealth providers, as they aim to strengthen cybersecurity by making many previous guidelines mandatory and introducing new, more specific requirements. In this article, we outline seven key changes from the Proposed Rule and outline how providers can prepare their practices once the Rule is in effect.

August 10, 2025
OIG

OIG Issues Advisory Opinion 25-03, A Roadmap for Compliant Telehealth Staffing Models

On June 6, 2025, the US Department of Health and Human Services’ Office of the Inspector General issued Advisory Opinion 25-03, offering key compliance guidance for telehealth arrangements involving the leasing of health care providers and other administrative services to a physician-owned professional corporation (PC). Learn more about the opinion and what it tells us about the future of telehealth regulatory compliance.

July 19, 2025
PBM Audit Victory

HLA Wins Full Reversal of PBM Audit Findings for Maryland Pharmacy

Health Law Alliance achieved full reversal of final audit findings for a Maryland pharmacy—just one of numerous victories our attorneys has achieved for our clients. Learn more about the stunning reversal and how Health Law Alliance’s tenacious advocacy can help your pharmacy in PBM disputes.

July 18, 2025
Telehealth Fraud

DOJ’s 2025 National Health Care Fraud Takedown: What it Means for Telehealth Providers

The DOJ’s 2025 National Health Care Fraud Takedown charged 324 people in schemes totaling $14 billion in intended losses, including $1.17 billion tied to telemedicine and genetic‑testing fraud that implicated 49 defendants - signaling the government’s continued crack‑down on virtual‑care abuses. The surge in criminal and civil actions, coupled with CMS suspensions and the new DOJ‑HHS False Claims Act Working Group, warns telehealth providers to rigorously audit their compliance practices or risk severe penalties and exclusion from federal programs.

July 12, 2025
Telehealth Audit

Telehealth Audit Season: OIG Found 7 Percent Error Rate in Pandemic-Era E/M Billing

A 2024 OIG study found that 7% of E/M services billed during the pandemic were noncompliant with Medicare billing requirements. We break down OIG’s findings and explain what they mean in an era where RPM audits are on the rise.

June 27, 2025
Patient Access in Telehealth

Balancing Patient Access and Privacy in Audio-Only Telehealth

Address the specific compliance and privacy challenges associated with audio-only telehealth services. This article will provide telehealth providers with actionable strategies to ensure compliance with privacy regulations, such as HIPAA, while effectively using audio-only visits to increase access to care.

June 11, 2025
Red Flags in Telehealth

10 Telehealth Fraud Red Flags (and How to Avoid Them)

Provide telehealth providers with a concise guide to recognizing and mitigating potential fraud risks. Each “red flag” will highlight a common scenario that could indicate fraud vulnerability, followed by practical steps to address it. With clear, actionable insights, the article will be an essential resource for telehealth providers aiming to safeguard their practice.

June 9, 2025
Doctor Acquitted

Federal Indictment Against NJ Doctor Collapses in Stunning DOJ Reversal

Health Law Alliance secured a full dismissal of all federal charges against NJ urologist Dr. Mukaram Gazi, marking an unprecedented acquittal in an otherwise unbroken string of 35 Insys-related prosecutions brought by federal and state prosecutors.

May 19, 2025
Telehealth Indictment

Provider Alert: New York Physician Indicted in Louisiana for Virtually Prescribing Abortion Medication

New York doctor indicted in Louisiana for prescribing abortion pills via telehealth, raising legal battles over state laws, shield protections, and provider risks post-Dobbs.

March 4, 2025
DEA New Rules

DEA Announces Three New Rules Expanding Telehealth Access

This article outlines the details of the three new telehealth rules promulgated by the Drug Enforcement Agency (DEA) and their impact on telehealth providers.

February 25, 2025
Remote Patient Monitoring

Remote Patient Monitoring: Know the Basics of Compliant Billing and Coding

In the article we outline the basics of RPM billing and coding, including which RPM services are billable by payor, the unique fraud risks associated with RPM, and best practices for providers to ensure their billing/coding procedures for RPM services are legally compliant.

February 18, 2025
Cross-State Licensing

Cross-State Licensing in Telehealth: Challenges, Solutions, and Opportunities

Explore the complexities and barriers telehealth providers face when offering services across state lines. This article will provide expert guidance on managing licensing requirements, navigating compacts, and understanding the legal limitations of interstate telehealth.

February 4, 2025
Telehealth Fraud Prevention

Telehealth and Fraud Prevention: Protecting Your Practice

Address the increasing scrutiny telehealth providers face regarding potential fraud, waste, and abuse in virtual care. This article delivers expert insights into structuring telehealth practices to avoid fraud allegations, including strategies for compliance with the Anti-Kickback Statute, Stark Law, and other relevant regulations.

January 17, 2025
Telehealth in 2025

Telehealth in 2025: Medicare Providers Get Temporary Relief, But Uncertainty Remains

The American Relief Act, 2025, temporarily extends key Medicare telehealth flexibilities through March 31, 2025, preserving access to remote care for now but leaving providers and patients uncertain about the future. This update outlines what the extension covers, highlights permanent changes, and offers guidance to help providers prepare for potential disruptions.

January 14, 2025
Telehealth in 2025

Telehealth in 2025: What Medicare Providers Should Know

During COVID-19, Medicare expanded telehealth access by waiving geographic restrictions, broadening provider eligibility, and covering more services. These temporary flexibilities are set to expire at the end of 2024, requiring providers to adjust to stricter pre-pandemic rules unless Congress intervenes.

December 15, 2024
Patient-Provider Relationships

Establishing and Documenting Patient-Provider Relationships in Telehealth

Actionable steps to properly establish, document, and maintain these relationships, minimizing risks and enhancing compliance.

December 6, 2024
Telehealth Compliance

Top 10 Telehealth Compliance Mistakes You Might Be Making Right Now (and How to Fix Them)

Top 10 list of common telehealth compliance mistakes, with practical advice on how to identify and correct each issue.

December 3, 2024
Telehealth Prescribing

DEA and HHS Extend COVID-19 Telehealth Prescribing Flexibilities Through 2025

Discuss the DEA/HHS joint rule extending the prescribing flexibilities for controlled substances. Include: 1) an overview of the prescribing flexibilities that emerged during the COVID pandemic re: controlled substances; 2) the details of the proposed rule, and 3) what the rule means for providers.

November 29, 2024
Reimbursements

Maximizing Reimbursement for Telehealth Services

Offer telehealth providers a practical guide to navigating billing and reimbursement challenges specific to virtual care. This article will delve into coding practices, reimbursement parity, and strategies to optimize revenue by understanding insurer requirements for telehealth.

November 26, 2024
Telehealth Consent

Navigating Informed Consent Requirements in Telehealth: A Provider’s Guide

We examine the complex requirements and risks associated with informed consent for telehealth providers. The article provides actionable advice on navigating the regulatory landscape and practical steps to ensure legal compliance and patient safety.

November 19, 2024
Free Consultation

Are You Under a Healthcare Investigation?

We defend physicians, pharmacists, and practices against DEA subpoenas, healthcare fraud allegations, PBM audits, and GLP-1 billing scrutiny.

Every hour matters in a healthcare investigation.

"I personally review every inquiry within 24 hours." — Anthony Mahajan

✓
Recent OutcomeDEA suspension lifted for Florida pharmacist — full authority restored in 48 hours.
5.0 · 47 Google reviews
Confidential
No Obligation
24hr Response